Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Vibrio cholerae O1 lipopolysaccharide O-antigen is a heat-stable polysaccharide found on the outer membrane of V. cholerae and is the principal determinant of the O1 serogroup[5][6]. It serves as the major surface antigen recognized by the host immune system, the primary target for protective antibody responses, and the receptor for certain bacteriophages[1][2][7]. Serogroup O1 strains, defined by the structure of this antigen, are responsible for epidemic and pandemic cholera, and the antigen's structural variants (serotypes Ogawa, Inaba, Hikojima) contribute to epidemiological diversity[5][7]. The O-antigen is central to current vaccine design and diagnostic efforts, but it is subject to phase variation and antigenic change, which can influence infectivity, immune evasion, and resistance to phage therapy[1][6][7]. Note: The term "Vibrio cholerae surface antigen" is not specific, and could equally refer to other surface structures, such as outer membrane proteins or alternative polysaccharide antigens. For structured scientific or therapeutic purposes, Vibrio cholerae O1 lipopolysaccharide O-antigen (or O1 antigen) is the precise canonical form for the major, therapeutically relevant surface antigen[1][5][7]. Further specification is necessary to avoid ambiguity.
Induction of protective immunity through generation of O-antigen–specific antibodies (as with killed whole-cell or conjugate vaccines). Bacteriophage therapy utilizes phages that recognize and bind the O-antigen to infect and lyse the bacterium.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae O1 lipopolysaccharide O-antigen (null).